NCT05040217: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment |
|
|
| Recruiting | 1 | 12 | US | AAV2-BDNF Gene Therapy, Growth Factor Gene Therapy | Mark Tuszynski, Ohio State University | Alzheimer's Disease, Mild Cognitive Impairment | 10/25 | 10/27 | | |